A questionable large study conducted in Brazil found that ivermectin allegedly reduced mortality by 92 percent against COVID-19. The study included over 100,000 participants, but nearly two-thirds of them, including participants who developed COVID-19 while taking ivermectin, were excluded from the analysis. The study’s authors published a similar poorly controlled study last year that claimed the drug cuts COVID-19 hospitalization and death in half.
Recommendation:
Low Risk Read More +
Emphasizing the flaws in the study’s methodology and analysis is recommended, as is emphasizing that multiple randomized and controlled clinical trials have found that ivermectin does not benefit COVID-19 patients. Fact-checking sources:
Sign Up for Public Health Alerts
About Us
The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans’ confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials.
Learn More
Learn More